ibalizumab
Selected indexed studies
- Ibalizumab. (, 2006) [PMID:30000027]
- Ibalizumab. (Curr Opin HIV AIDS, 2018) [PMID:29746266]
- Ibalizumab: First Global Approval. (Drugs, 2018) [PMID:29675744]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ibalizumab. (2006) pubmed
- Ibalizumab. (2018) pubmed
- Ibalizumab: First Global Approval. (2018) pubmed
- Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection. (2020) pubmed
- Ibalizumab. (2012) pubmed
- Ibalizumab, a Novel Monoclonal Antibody for the Management of Multidrug-Resistant HIV-1 Infection. (2019) pubmed
- Ibalizumab: The First Monoclonal Antibody for the Treatment of HIV-1 Infection. (2021) pubmed
- Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients. (2018) pubmed
- Ibalizumab for the treatment of multidrug-resistant HIV-1 infection. (2019) pubmed
- Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates. (2022) pubmed